Wearable-tracked activity after starting GLP-1 treatments examines real-world movement using fitness-device data, prompting consideration of everyday fitness implications.
Key Takeaways
- Analysis of Fitbit users found average daily step counts decreased after treatment initiation
- Measured exercise intensity and weekly active minutes also declined after starting therapy
- Medications were associated with reductions in lean muscle mass and strength concerns